Home/Investors/National Institute on Drug Abuse (NIDA)

National Institute on Drug Abuse (NIDA)

Biotech Investor · 3 portfolio companies

Portfolio
3
Focus Areas
10
Top Stage
Phase 1

Portfolio Companies

CompanyValuation
Advanced Brain Monitoring
Mebias Discovery
Sparian Biosciences